Lansoprazole pellets is an API that works as a second-generation proton pump inhibitor. This molecule is effective in the ulcer treatment. It is also synthesized making use of a non-infringing route. The pellets have demand in the regulatory market for the use of non-infringing excipients and aqueous coatings.
NAME :- LANSOPRAZOLE PELLETS
IUPAC NAME :- 2-3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl methylsulfinyl -1H-benzimidazole
CAS NO. :- 103577-45-3
FORMULA :- C16H14F3N3O2S
SYNONYMS :- lansoprazole, Prevacid, Monolitum, Bamalite, Takepron, Agopton, Ogastro, Lanzor, Opiren, Zoton, Limpidex, Prezal, Ulpax, lanzoprazole, Lanproton, Lansopep, Lanzopral, Lasoprol, Mesactol, Prosogan
APPLICATION :- Treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, duodenal ulcers, Helicobacter pylori (H. pylori) infections,stomach ulcers, prevention of stomach ulcers in those people taking non-sal anti-inflammatory drugs (NSAIDs), such as ibuprofen,pathological hypersecretory conditions (such as Zollinger-Ellison syndrome).
DESCRIPTION :- Lansoprazole Pellets is a second-generation proton pump inhibitor and is one of the blockbuster molecules that are used in the treatment of ulcer. The API used for manufacture is synthesized using a non-infringing route. The use of non-infringing excipients and aqueous coatings makes it aptly suitable for the regulatory market.